JNNP

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

Journal of Neurology, Neurosurgery, and Psychiatry 2006;77:1177-1179; doi:10.1136/jnnp.2005.078345
Copyright © 2006 by the BMJ Publishing Group Ltd.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bonifati, D M
Right arrow Articles by Pegoraro, E
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bonifati, D M
Right arrow Articles by Pegoraro, E
Related Collections
Right arrow Other Neurology
Right arrowRelated Article

PAPER

The glucocorticoid receptor N363S polymorphism and steroid response in Duchenne dystrophy

D M Bonifati1, S F Witchel2, M Ermani1, E P Hoffman3, C Angelini1, E Pegoraro1

1 Department of Neurosciences, University of Padova, Italy
2 Children’s Hospital of Pittsburgh, Division of Pediatric Endocrinology, Pittsburgh, PA, USA
3 Center for Genetic Medicine, Children’s Research Hospital, Washington, DC, USA

Correspondence to:
Correspondence to:
Dr E Pegoraro
Department of Neurosciences, University of Padova, via Giustiniani 5, 35128 Padova, Italy; elena.pegoraro{at}unipd.it

Background: Steroid administration is beneficial in Duchenne muscular dystrophy (DMD), but the response, incidence, and the severity of side effects are variable.

Aims: To investigate whether glucocorticoid receptor (GRL) gene polymorphisms may be responsible for glucocorticoid sensitivity in DMD.

Methods: Forty eight DMD patients treated either with prednisone or deflazacort were subjected to genetic analyses of the GRL gene.

Results: Mutation studies revealed an heterozygous A to G mutation at GRL cDNA position 1220 in three DMD patients resulting in an asparagine to serine amino acid change at amino acid position 363 (N363S). The N363S carrier DMD patients showed a trend towards a later age at loss of ambulation in comparison with non-carrier patients.

Conclusions: These data suggest that the N363S GRL polymorphism may be implicated in the long term response to glucocorticoids.


Abbreviations: DMD, Duchenne muscular dystrophy; PCR, polymerase chain reaction; SSCP, single strand conformational polymorphism

Keywords: Duchenne muscular dystrophy; glucocorticoid receptor; SNP; steroid therapy


Related Article

Predicting steroid response in muscle disease
N Nirmalananthan and M G Hanna
J. Neurol. Neurosurg. Psychiatry 2006 77: 1104-1105. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
J. Neurol. Neurosurg. PsychiatryHome page
N Nirmalananthan and M G Hanna
Predicting steroid response in muscle disease
J. Neurol. Neurosurg. Psychiatry, October 1, 2006; 77(10): 1104 - 1105.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2006 by the BMJ Publishing Group Ltd.